Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)
Active, not recruiting · NCT03998254 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-09-01 | NCT03998254 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lingchuan Center for Disease Control and Prevention ( Site 0002) | Guilin | China | 1 |
| Mianyang Center for Disease Control and Prevention ( Site 0005) | Mianyang | China | 1 |
| Quanzhou Center for Disease Control and Prevention ( Site 0001) | Guilin | China | 1 |
| Santai County Center for Disease Control and Prevention ( Site 0006) | Mianyang | China | 1 |
| Xiangyuan Center for Disease Control and Prevention ( Site 0003) | Changzhi | China | 1 |
| Yanhu Center for Disease Control and Prevention of Yuncheng ( Site 0004) | Yuncheng | China | 1 |